| AC IMMUNE SA SF-,02 |
| Schweiz |
| Gesundheit |
| CH0329023102 / A2AR5F |
| IMR (Frankfurt) / ACIU (NASDAQ) |
| FRA:IMR, ETR:IMR, IMR:GR, NASDAQ:ACIU |
| - |
| https://www.acimmune.com/ |
|
AC Immune SA is a clinical-stage biopharmaceutical company focused on precision medicine for neurodegenerative diseases, including Alzheimer’s disease, Parkinson’s disease, and NeuroOrphan indications driven by misfolded proteins. The company des..
>Volltext.. |
| 235.32 Mio. EUR |
| 143.05 Mio. EUR |
| 3.66 Mio. EUR |
| -68.29 Mio. EUR |
| -72.44 Mio. EUR |
| -0.72 EUR |
| 4.91 Mio. EUR |
| 28.96 Mio. EUR |
| -74.22 Mio. EUR |
| 0.97 |
| -88.02% |
| -30.25% |
| - |
| - |
| - |
| - |
| AC IMMUNE |
| 08.04.26 |
|